Clinical effect evaluation of Thymosin combined with antituberculosis drugs in the treatment of multi-drug resistant tuberculosis
XU Jiang-tao1 HU Xiao-hong2 WANG Yu-min3
1.Shenyang Chest Hospital,Liaoning Province,Shenyang 110044,China;
2.Department of Cadre,Northern Theater Command Air Force Hospital,Liaoning Province,Shenyang 110015,China;
3.Medical Team,Security Department,the Fifth Brigade of Air Force Information,Northern Theater Command,Liaoning Province,Shenyang 110015,China
Abstract：Objective To investigate the therapeutic effect of Thymosin combined with antituberculosis drugs in the treatment of multi-drug resistant tuberculosis.Methods From December 7,2015 to January 1,2017,68 patients with multi-drug resistant tuberculosis treated in Shenyang Chest Hospital were selected as subjects.They were evenly divided into two groups according to the complete random principle,34 cases in each group.according to different treatment methods.In the control group,conventional anti-tuberculosis drug treatment was used,while on the basis of the control group,Thymosin was added in the observation group.The biochemical indicators,sputum negative conversion,cavity closure and occurrence of adverse events were observed.Results There was no statistically significant difference between the two groups of patients before and after treatment of hemoglobin,alanine transaminase and urea nitrogen levels(P＞0.05).Treatment for 3 months,treatment for half year and end of treatment,the rates of sputum negative conversion in the observation group(52.94%,64.71%,73.53%)were higher than those of the control group(29.41%,38.24%,44.12%),and the differences were statistically significant(P＜0.05).Treatment for 3 months and end of treatment,the rates of cavity closure in the observation group(29.41%,55.88%)were higher than those of the control group(5.88%,32.35%),and the differences were statistically significant(P＜0.05),while there was no statistically significant difference of the cavity closure rate between two groups of treatment for half year(P＞0.05).There was no statistically significant difference in the incidence of adverse events between the two groups (P＞0.05).Conclusion In the treatment of multi-drug resistant tuberculosis,anti-tuberculosis drugs combined with Thymosin has a great effect,which can significantly alleviate the disease condition and promote the recovery in high safety.
京公网安备 11010502046607号